GILEAD SCIENCES INC (GILD) is a publicly traded company in the Unknown sector. Across all available filings, 36 corporate insiders have executed 1084 transactions totaling $522.3M, demonstrating a bearish sentiment with -$522.3M in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 74,461 shares valued at $10.7M.
No significant insider buying has been recorded for GILD in the recent period.
No significant insider selling has been recorded for GILD in the recent period.
Based on recent SEC filings, insider sentiment for GILD is bearish with an Insider Alignment Score of 0/100 and a net flow of -$522.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GILEAD SCIENCES INC (GILD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 36 insiders are actively trading GILD stock, having executed 1084 transactions in the past 90 days. The most active insider is John C. Martin (Executive), who has made 133 transactions totaling $307.7M.
Get notified when executives and directors at GILD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Patrick O'day Daniel | Executive | Payment | 74,461 | $143.28 | $10.7M | Large |
| Feb 3, 2026 | Patrick O'day Daniel | Executive | Award | 131,675 | $N/A | $0 | |
| Feb 3, 2026 | D. Dickinson Andrew | Chief Financial Officer | Payment | 24,802 | $143.28 | $3.6M | C-SuiteLarge |
| Feb 3, 2026 | D. Dickinson Andrew | Chief Financial Officer | Award | 44,867 | $N/A | $0 | C-Suite |
| Feb 3, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | Payment | 24,800 | $143.28 | $3.6M | Large |
| Feb 3, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | Award | 44,867 | $N/A | $0 | |
| Jan 23, 2026 | Patrick O'day Daniel | Executive | Option Exercise | 115,640 | $N/A | $0 | |
| Jan 23, 2026 | Patrick O'day Daniel | Executive | Sale | 115,640 | $135.00 | $15.6M | Large |
| Jan 23, 2026 | Patrick O'day Daniel | Executive | Option Exercise | 115,640 | $66.01 | $7.6M | Large |
| Jan 15, 2026 | Mercier Johanna | Chief Commercial Officer | Sale | 3,000 | $124.31 | $372.9K | |
| Jan 15, 2026 | D. Dickinson Andrew | Chief Financial Officer | Sale | 3,000 | $124.31 | $372.9K | C-Suite |
| Jan 2, 2026 | Berger Dietmar | Chief Medical Officer | Option Exercise | 16,326 | $N/A | $0 | |
| Jan 2, 2026 | Berger Dietmar | Chief Medical Officer | Payment | 6,944 | $121.60 | $844.4K | Large |
| Jan 2, 2026 | Berger Dietmar | Chief Medical Officer | Option Exercise | 16,326 | $N/A | $0 | |
| Dec 29, 2025 | Patrick O'day Daniel | Executive | Sale | 10,000 | $124.83 | $1.2M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 300 | $522.3M | 68.0% |
Exercise(M) | 386 | $140.7M | 18.3% |
Payment(F) | 192 | $103.9M | 13.5% |
Will Acquisition(W) | 1 | $1.0M | 0.1% |
Award(A) | 159 | $695.9K | 0.1% |
Gift(G) | 38 | $0 | 0.0% |
Other(J) | 8 | $0 | 0.0% |
Insider selling pressure at GILEAD SCIENCES INC has increased, with 36 insiders executing 1084 transactions across all time. Total sales of $522.3M significantly outpace purchases of $0, resulting in a net outflow of $522.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.